Skip to main content

Anastomosis, Functional

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GT Biopharma
GT BiopharmaSAN FRANCISCO, CA
1 program
Magnet SystemN/A
GT Metabolic Solutions
GT Metabolic SolutionsMN - St. Michael
1 program
Magnet SystemN/A2 trials
Active Trials
NCT07609511Not Yet Recruiting10Est. Dec 2026
NCT07431723Recruiting50Est. Feb 2028

Trial Timeline

Clinical trial activity over time

2026
2027
2028
GT Metabolic SolutionsMagnet System
GT Metabolic SolutionsMagnet System

Clinical Trials (2)

Total enrollment: 60 patients across 2 trials

Magnet System Gastric Outlet Obstruction Study

Start: Jul 2026Est. completion: Dec 202610 patients
N/ANot Yet Recruiting

Creation of Compression Anastomosis Using the GT Metabolic Magnet System

Start: Feb 2026Est. completion: Feb 202850 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 60 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.